IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Atorvastatin loading before percutaneous coronary intervention down-regulates Toll-like receptor4 expression and ameliorates myocardial injury markers

Author: NAJAH HADI, SAHAR A. MAJEED, KHALID I. AMBER, GHIZAL FATIMA, AHMED N REGEEB, NASSER GHALY YOUSIF, RAM SINGH
Abstract: The aim of the study was to assess the activity of pre-PCI atorvastatin reload on the acute inflammatory responses and in Toll-Like Receptor 4 expressions with its downstream signaling. A double-blind randomized prospective study, 30 patients who received low dose atorvastatin 40 mg/day without reload. While, 30 patients who were already on the usual dose of atorvastatin with further 80 mg & 40 mg at 12 and 2 hrs before PCI respectively. TLR4 expression in peripheral monocyte investigate by flow cytometry, and cardiac troponin I, CK-MB, HsCRP and HMG-BOX protein by ELISA technique immediately before and at 4 hrs, 12 hrs. After PCI. Stent implantation was associated with an elevation in TLR 4 expression in peripheral monocyte of both study groups after stenting with higher expression level was found among control group (p<0.05) at 4 hr and 12 hr post-PCI. HsCRP, HMGbox1protein were lower in atorvastatin reload group (p<0.05), and the myocardial injury markers (CKMB, troponin I) were significantly higher among the control group than atorvastatin reload group (p<0.05). Atorvastatin attenuated toll-like receptor 4 expressions on peripheral monocyte subsequently its downstream effects HsCRP and HMGBOX1-protein.
Keyword: Toll-like receptor2, Atorvastatinre, Percutaneous coronary intervention, myocardial injury markers
DOI: https://doi.org/10.31838/ijpr/2019.11.03.056
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477